Prior reports on patient uterine cervix cancer tumors using nonstandard methods for GRPR expression demonstrated that up to 88% of cancer cases express GRPR and that overall GRPR expression prevails in endocervical neoplasia (7–9). Here, GRPR is linked to cervical cancer.